Condition: Rheumatoid Arthritis · Sponsor: Hoffmann-La Roche
This study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate response or intolerance to TNF and/or JAK inhibitors.
This description comes directly from the study's public registry record.
Reference Study ID Number: WA45846 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global.rochegenentechtrials@roche.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| SunValley Arthritis Center Ltd. | Peoria, Arizona, United States | Recruiting |
| University of California Medical Center | La Jolla, California, United States | Recruiting |
| Cedars Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Inland Rheumatology Clinical Trials Incorporated | Upland, California, United States | Recruiting |
| West Broward Rheumatology Associates, Inc. | Tamarac, Florida, United States | Recruiting |
| Willow Rheumatology and Wellness PLLC | Willowbrook, Illinois, United States | Recruiting |
| Accurate Clinical Research Inc. | Lake Charles, Louisiana, United States | Recruiting |
| Ohio State University Wexner Medical Center | Columbus, Ohio, United States | Recruiting |
| Altoona Center For Clinical Research | Duncansville, Pennsylvania, United States | Recruiting |
| Accurate Clinical Management | Houston, Texas, United States | Recruiting |
| DM Clinical Research | Tomball, Texas, United States | Recruiting |
| Tidewater Clinical Research | Chesapeake, Virginia, United States | Recruiting |
+ 44 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07137598